Table 1. Attributable morbidity to HAP in Moroccan patients with COPD in 2019.
| Morbidity | |||
|---|---|---|---|
| Men | Women | ||
| RR (95% CI)8 | 1.70 (1.47 to 1.97) |
1.70 (1.47 to 1.97) |
|
| Proportion of the Moroccan population exposed to HAP (95% CI) |
24.0% (19.5% to 28.5%) |
48.3% (43.5% to 53.1%) |
|
| PAF (95% CI) |
14.4% (8.4% to 21.6%) |
25.3% (17.0% to 34.0%) |
|
| Prevalence of disease | According to the modelling analysis22 | 14.4% | 6.2% |
| According to the BOLD I study14 | 16.6% | 8.3% | |
| Moroccan population21 | 18 280 000 | 18 020 000 | |
| Number of cases (Prevalence of disease × Moroccan population) |
According to the modelling analysis22 | 2 632 320 | 1 117 240 |
| According to the BOLD I study14 | 3 034 480 | 1 495 660 | |
| HAP-related cases (95% CI) (Number of cases × PAF) |
According to the modelling analysis22 | 379 055 (221 115 to 568 582) |
282 662 (189 931 to 379 862) |
| 661 717* (411 046 to 948 444) | |||
| According to the BOLD I study14 | 436 966 (254 897 to 655 448) |
378 402 (254 263 to 508 525) |
|
| 815 368* (509 160 to 1 163 973) | |||
*
Total of HAP-related cases (95% CI).
BOLD, Burden of Obstructive Lung Disease; COPD, chronic obstructive pulmonary disease; HAP, household air pollution; PAF, population attributable fraction; RR, relative risk.